Sign in to view content

Effects of Ketoconazole on Clinical Recovery, Choroidal Thickness and Hormonal Profile in Patients With Central Serous Chorioretinopathy

Yodpong Chantarasorn, MD

Video
Published 2020

Related

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018
Episode 16: PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy with Dr. Camiel Boon
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Obstructive Sleep Apnea and Its Treatment Alter Choroidal Thickness in Patients With Central Serous Chorioretinopathy
Carolyn K Pan, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more